Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 5/2019

01-05-2019 | Ultrasound | Review

Fusion Imaging and Virtual Navigation to Guide Percutaneous Thermal Ablation of Hepatocellular Carcinoma: A Review of the Literature

Authors: Marco Calandri, Giovanni Mauri, Steven Yevich, Carlo Gazzera, Domenico Basile, Marco Gatti, Andrea Veltri, Paolo Fonio

Published in: CardioVascular and Interventional Radiology | Issue 5/2019

Login to get access

Abstract

As medical imaging advancements have improved the detectability of hepatocellular carcinoma (HCC) in early stages, the approach to percutaneous thermal ablation for curative treatment has concomitantly advanced. Although many centers are adopting cross-sectional imaging to guide percutaneous ablation, the majority of procedures are still performed under ultrasound (US) guidance worldwide. Challenges to ultrasound guidance may present due to relatively poor resolution particularly with small or isoechoic lesions, or due to intervening structures such as the bowel or diaphragm that obstruct lesional visualization. Fusion imaging (FI) systems have been employed to address these challenges. By merging or synchronizing the real-time images from US with a previously obtained cross-sectional study, FI mitigates the inherent limitations of each individual imaging modality and expands procedural feasibility and technical outcomes. This manuscript reviews the current literature on the use of FI during percutaneous thermal ablation of HCC.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRefPubMed
2.
go back to reference Livraghi T, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2007;47(1):82–9.CrossRef Livraghi T, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2007;47(1):82–9.CrossRef
3.
go back to reference Choi D, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17(3):684–92.CrossRefPubMed Choi D, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17(3):684–92.CrossRefPubMed
4.
go back to reference Samanci C, et al. Magnetic resonance imaging in diagnosis and monitoring of hepatocellular carcinoma in liver transplantation: a comprehensive review. Ann Transplant. 2016;21:68–76.CrossRefPubMed Samanci C, et al. Magnetic resonance imaging in diagnosis and monitoring of hepatocellular carcinoma in liver transplantation: a comprehensive review. Ann Transplant. 2016;21:68–76.CrossRefPubMed
5.
go back to reference Park HJ, Lee JM, Park SB, Lee JB, Jeong YK, Yoon JH. Comparison of knowledge-based iterative model reconstruction and hybrid reconstruction techniques for liver CT evaluation of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 2016;40(6):863–71.CrossRefPubMed Park HJ, Lee JM, Park SB, Lee JB, Jeong YK, Yoon JH. Comparison of knowledge-based iterative model reconstruction and hybrid reconstruction techniques for liver CT evaluation of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 2016;40(6):863–71.CrossRefPubMed
6.
go back to reference Mauri G, et al. Real-Time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38(1):143–51.CrossRefPubMed Mauri G, et al. Real-Time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38(1):143–51.CrossRefPubMed
7.
go back to reference Hakime A, Yevich S, Tselikas L, Deschamps F, Petrover D, De Baere T. Percutaneous thermal ablation with ultrasound guidance. Fusion imaging guidance to improve conspicuity of liver metastasis. Cardiovasc Intervent Radiol. 2017;40(5):721–7.CrossRefPubMed Hakime A, Yevich S, Tselikas L, Deschamps F, Petrover D, De Baere T. Percutaneous thermal ablation with ultrasound guidance. Fusion imaging guidance to improve conspicuity of liver metastasis. Cardiovasc Intervent Radiol. 2017;40(5):721–7.CrossRefPubMed
8.
go back to reference Lee MW, et al. Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. Am J Roentgenol. 2010;194(5):W396–400.CrossRef Lee MW, et al. Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. Am J Roentgenol. 2010;194(5):W396–400.CrossRef
9.
go back to reference Kunishi Y, et al. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI With Gd-EOB-DTPA to detect small hepatocellular carcinoma. Am J Roentgenol. 2012;198(1):106–14.CrossRef Kunishi Y, et al. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI With Gd-EOB-DTPA to detect small hepatocellular carcinoma. Am J Roentgenol. 2012;198(1):106–14.CrossRef
10.
go back to reference Jo PC, Jang H-J, Burns PN, Burak KW, Kim TK, Wilson SR. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do it. Radiology. 2017;282(2):317–31.CrossRefPubMed Jo PC, Jang H-J, Burns PN, Burak KW, Kim TK, Wilson SR. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do it. Radiology. 2017;282(2):317–31.CrossRefPubMed
11.
go back to reference Dong Y, Wang W-P, Mao F, Ji Z-B, Huang B-J. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound: hepatocellular carcinoma imaging fusion. J Gastroenterol Hepatol. 2016;31(4):822–8.CrossRefPubMed Dong Y, Wang W-P, Mao F, Ji Z-B, Huang B-J. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound: hepatocellular carcinoma imaging fusion. J Gastroenterol Hepatol. 2016;31(4):822–8.CrossRefPubMed
12.
go back to reference Mauri G, et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5(2):209–16.CrossRefPubMedPubMedCentral Mauri G, et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5(2):209–16.CrossRefPubMedPubMedCentral
13.
go back to reference Claudon M, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39(2):187–210.CrossRefPubMed Claudon M, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39(2):187–210.CrossRefPubMed
14.
go back to reference Weiss J, Hoffmann R, Clasen S. MR-guided liver interventions: top. Magn Reson Imaging. 2018;27(3):163–70.CrossRef Weiss J, Hoffmann R, Clasen S. MR-guided liver interventions: top. Magn Reson Imaging. 2018;27(3):163–70.CrossRef
15.
go back to reference Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol. 2011;34(4):852–6.CrossRefPubMed Bale R, Widmann G, Haidu M. Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol. 2011;34(4):852–6.CrossRefPubMed
16.
go back to reference Braak SJ, van Strijen MJL, van Leersum M, van Es HW, van Heesewijk JPM. Real-time 3D fluoroscopy guidance during needle interventions: technique, accuracy, and feasibility. Am J Roentgenol. 2010;194(5):W445–51.CrossRef Braak SJ, van Strijen MJL, van Leersum M, van Es HW, van Heesewijk JPM. Real-time 3D fluoroscopy guidance during needle interventions: technique, accuracy, and feasibility. Am J Roentgenol. 2010;194(5):W445–51.CrossRef
17.
go back to reference Maybody M, Stevenson C, Solomon SB. Overview of navigation systems in image-guided interventions. Tech Vasc Interv Radiol. 2013;16(3):136–43.CrossRefPubMed Maybody M, Stevenson C, Solomon SB. Overview of navigation systems in image-guided interventions. Tech Vasc Interv Radiol. 2013;16(3):136–43.CrossRefPubMed
18.
go back to reference Minami Y, et al. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma. Eur Radiol. 2018;28(5):1986–93.CrossRefPubMed Minami Y, et al. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma. Eur Radiol. 2018;28(5):1986–93.CrossRefPubMed
19.
go back to reference Ewertsen C, Săftoiu A, Gruionu LG, Karstrup S, Nielsen MB. Real-time image fusion involving diagnostic ultrasound. Am J Roentgenol. 2013;200(3):W249–55.CrossRef Ewertsen C, Săftoiu A, Gruionu LG, Karstrup S, Nielsen MB. Real-time image fusion involving diagnostic ultrasound. Am J Roentgenol. 2013;200(3):W249–55.CrossRef
20.
go back to reference Lee MW, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. Am J Roentgenol. 2012;198(6):1438–44.CrossRef Lee MW, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. Am J Roentgenol. 2012;198(6):1438–44.CrossRef
21.
go back to reference Li K, Su Z-Z, Xu E-J, Ju J-X, Meng X-C, Zheng R-Q. Improvement of ablative margins by the intraoperative use of CEUS–CT/MR image fusion in hepatocellular carcinoma. BMC Cancer. 2016;16(1):277.CrossRefPubMedPubMedCentral Li K, Su Z-Z, Xu E-J, Ju J-X, Meng X-C, Zheng R-Q. Improvement of ablative margins by the intraoperative use of CEUS–CT/MR image fusion in hepatocellular carcinoma. BMC Cancer. 2016;16(1):277.CrossRefPubMedPubMedCentral
23.
go back to reference Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.CrossRefPubMedPubMedCentral Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.CrossRefPubMedPubMedCentral
24.
go back to reference Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. Am J Roentgenol. 2008;190(5):1324–30.CrossRef Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. Am J Roentgenol. 2008;190(5):1324–30.CrossRef
25.
go back to reference Kim J-E, et al. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011;79(2):e80–4.CrossRefPubMed Kim J-E, et al. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011;79(2):e80–4.CrossRefPubMed
26.
go back to reference Bo X-W, et al. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol. 2016;89(1067):20160379.CrossRefPubMedPubMedCentral Bo X-W, et al. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol. 2016;89(1067):20160379.CrossRefPubMedPubMedCentral
27.
go back to reference Kim PN, et al. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. J Vasc Interv Radiol. 2012;23(5):627–34.CrossRefPubMed Kim PN, et al. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. J Vasc Interv Radiol. 2012;23(5):627–34.CrossRefPubMed
28.
go back to reference Makino Y, et al. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Oncology. 2013;84(s1):44–50.CrossRefPubMed Makino Y, et al. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Oncology. 2013;84(s1):44–50.CrossRefPubMed
29.
go back to reference Lee MW, Rhim H, Ik Cha D, Jun Kim Y, Lim HK. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1–3 cm): value of fusion imaging with conventional US and CT/MR images. J Vasc Interv Radiol. 2013;24(7):958–65.CrossRefPubMed Lee MW, Rhim H, Ik Cha D, Jun Kim Y, Lim HK. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1–3 cm): value of fusion imaging with conventional US and CT/MR images. J Vasc Interv Radiol. 2013;24(7):958–65.CrossRefPubMed
30.
go back to reference Matsui O, et al. Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging. 2011;36(3):264–72.CrossRefPubMedPubMedCentral Matsui O, et al. Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging. 2011;36(3):264–72.CrossRefPubMedPubMedCentral
31.
go back to reference Sultana S, et al. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector ct scanner to time arterial phase imaging. Radiology. 2007;243(1):140–7.CrossRefPubMed Sultana S, et al. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector ct scanner to time arterial phase imaging. Radiology. 2007;243(1):140–7.CrossRefPubMed
32.
go back to reference Arif-Twari H, et al. MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol. 2014;20(3):209–21.CrossRef Arif-Twari H, et al. MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol. 2014;20(3):209–21.CrossRef
33.
go back to reference Lee JY, Choi BI, Chung YE, Kim MW, Kim SH, Han JK. Clinical value of CT/MR-US fusion imaging for radiofrequency ablation of hepatic nodules. Eur J Radiol. 2012;81(9):2281–9.CrossRefPubMed Lee JY, Choi BI, Chung YE, Kim MW, Kim SH, Han JK. Clinical value of CT/MR-US fusion imaging for radiofrequency ablation of hepatic nodules. Eur J Radiol. 2012;81(9):2281–9.CrossRefPubMed
34.
go back to reference Song KD, et al. Percutaneous US/MRI fusion–guided radiofrequency ablation for recurrent subcentimeter hepatocellular carcinoma: technical feasibility and therapeutic outcomes. Radiology. 2018;288(3):878–86.CrossRefPubMed Song KD, et al. Percutaneous US/MRI fusion–guided radiofrequency ablation for recurrent subcentimeter hepatocellular carcinoma: technical feasibility and therapeutic outcomes. Radiology. 2018;288(3):878–86.CrossRefPubMed
35.
go back to reference Minami T, et al. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology. 2014;87(s1):55–62.CrossRefPubMed Minami T, et al. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology. 2014;87(s1):55–62.CrossRefPubMed
36.
go back to reference Min JH, et al. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol. 2014;20(1):61.CrossRefPubMedPubMedCentral Min JH, et al. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol. 2014;20(1):61.CrossRefPubMedPubMedCentral
37.
go back to reference Xu Z-F, et al. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance: percutaneous RFA of malignant liver tumors. J Clin Ultrasound. 2014;42(6):321–30.CrossRefPubMed Xu Z-F, et al. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance: percutaneous RFA of malignant liver tumors. J Clin Ultrasound. 2014;42(6):321–30.CrossRefPubMed
38.
go back to reference Ahn SJ, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66(2):347–54.CrossRefPubMed Ahn SJ, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66(2):347–54.CrossRefPubMed
39.
go back to reference Brunello F, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol. 2008;43(6):727–35.CrossRefPubMed Brunello F, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol. 2008;43(6):727–35.CrossRefPubMed
40.
go back to reference Lim S, et al. Mistargeting after fusion imaging-guided percutaneous radiofrequency ablation of hepatocellular carcinomas. J Vasc Interv Radiol. 2014;25(2):307–14.CrossRefPubMed Lim S, et al. Mistargeting after fusion imaging-guided percutaneous radiofrequency ablation of hepatocellular carcinomas. J Vasc Interv Radiol. 2014;25(2):307–14.CrossRefPubMed
41.
42.
go back to reference Bo X-W, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol. 2017;90(1078):20170063.CrossRefPubMedPubMedCentral Bo X-W, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol. 2017;90(1078):20170063.CrossRefPubMedPubMedCentral
43.
go back to reference Xu E-J, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperth. 2017;34:1–7. Xu E-J, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperth. 2017;34:1–7.
44.
go back to reference Yang M, Ding H, Zhu L, Wang G. Ultrasound fusion image error correction using subject-specific liver motion model and automatic image registration. Comput Biol Med. 2016;79:99–109.CrossRefPubMed Yang M, Ding H, Zhu L, Wang G. Ultrasound fusion image error correction using subject-specific liver motion model and automatic image registration. Comput Biol Med. 2016;79:99–109.CrossRefPubMed
45.
go back to reference Mauri G et al. Virtual navigator automatic registration technology in abdominal application, In: Conference on proceedings of the annual international conference of the IEEE engineering in medicine and biology society, vol 2014; 2014, p. 5570–4. Mauri G et al. Virtual navigator automatic registration technology in abdominal application, In: Conference on proceedings of the annual international conference of the IEEE engineering in medicine and biology society, vol 2014; 2014, p. 5570–4.
46.
go back to reference Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. Am J Roentgenol. 2013;201(5):1141–7.CrossRef Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. Am J Roentgenol. 2013;201(5):1141–7.CrossRef
47.
go back to reference Min JH, et al. Local tumour progression after loco-regional therapy of hepatocellular carcinomas: value of fusion imaging-guided radiofrequency ablation. Clin Radiol. 2014;69(3):286–93.CrossRefPubMed Min JH, et al. Local tumour progression after loco-regional therapy of hepatocellular carcinomas: value of fusion imaging-guided radiofrequency ablation. Clin Radiol. 2014;69(3):286–93.CrossRefPubMed
48.
go back to reference Park HJ, et al. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography. Clin Radiol. 2015;70(4):387–94.CrossRefPubMed Park HJ, et al. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography. Clin Radiol. 2015;70(4):387–94.CrossRefPubMed
49.
go back to reference Makino Y, et al. Feasibility of extracted-overlay fusion imaging for intraoperative treatment evaluation of radiofrequency ablation for hepatocellular carcinoma. Liver Cancer. 2016;5(4):269–79.CrossRefPubMedPubMedCentral Makino Y, et al. Feasibility of extracted-overlay fusion imaging for intraoperative treatment evaluation of radiofrequency ablation for hepatocellular carcinoma. Liver Cancer. 2016;5(4):269–79.CrossRefPubMedPubMedCentral
50.
go back to reference Ewertsen C, Henriksen B, Torp-Pedersen S, Bachmann Nielsen M. Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI. Ultraschall Med Eur J Ultrasound. 2011;32(2):191–7.CrossRef Ewertsen C, Henriksen B, Torp-Pedersen S, Bachmann Nielsen M. Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI. Ultraschall Med Eur J Ultrasound. 2011;32(2):191–7.CrossRef
51.
go back to reference Makino Y, et al. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma. Dig Dis. 2013;31(5–6):485–9.CrossRefPubMed Makino Y, et al. Usefulness of the extracted-overlay function in CT/MR-ultrasonography fusion imaging for radiofrequency ablation of hepatocellular carcinoma. Dig Dis. 2013;31(5–6):485–9.CrossRefPubMed
52.
go back to reference Numata K, et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol. 2012;81(10):2746–53.CrossRefPubMed Numata K, et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol. 2012;81(10):2746–53.CrossRefPubMed
53.
go back to reference Xu E, et al. Comparison of CT/MRI–CEUS and US–CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperth. 2018;35:1–9.CrossRef Xu E, et al. Comparison of CT/MRI–CEUS and US–CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperth. 2018;35:1–9.CrossRef
Metadata
Title
Fusion Imaging and Virtual Navigation to Guide Percutaneous Thermal Ablation of Hepatocellular Carcinoma: A Review of the Literature
Authors
Marco Calandri
Giovanni Mauri
Steven Yevich
Carlo Gazzera
Domenico Basile
Marco Gatti
Andrea Veltri
Paolo Fonio
Publication date
01-05-2019
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 5/2019
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-019-02167-z

Other articles of this Issue 5/2019

CardioVascular and Interventional Radiology 5/2019 Go to the issue